Neutrons reveal potential dangers of gold nanoparticles—pharma's drug...
Scientists working at the Institut Laue-Langevin have shown that the charge of gold nanoparticles, identified by major pharmaceutical companies as a drug delivery agent of the future for the treatment...
View ArticleTaking stock of technology
At the recent Harvard IT Summit, Anne Margulies, vice president and University chief information officer, mentioned how Harvard had been at the forefront of information technology since its inception,...
View ArticleDon't stand so close: The downside of suppliers getting cozy with their...
Specialty suppliers such as those that cluster around the technology industry in the Silicon Valley and the auto industry in Detroit foster economic growth, right?
View ArticleNanosensors could aid drug manufacturing
MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs—especially those based on...
View ArticleVeeva Systems stock soars on debut
Shares of Veeva Systems Inc. are soaring in their trading debut Wednesday after the cloud-based software company raised about $261 million in its initial public offering.
View ArticleSwiss reject plan to cap managers' pay
Swiss voters soundly rejected on Sunday a proposal to limit the pay of companies' highest-paid managers to 12 times that of their lowest-paid workers, a plan that business leaders had warned could...
View ArticleMU researchers develop advanced 3-D 'force microscope'
Membrane proteins are the "gatekeepers" that allow information and molecules to pass into and out of a cell. Until recently, the microscopic study of these complex proteins has been restricted due to...
View ArticleAre you big pharma's new target market?
By 2018, it is estimated that the global pharmaceutical market will be worth more than $1.3 trillion USD. To corner their share of profits, established drug companies have to fight fierce competition...
View ArticleHealth care organizations under siege from cyberattacks, study says
Add this to the list of reasons for consumers to fret over privacy: Health care organizations of all kinds are being routinely attacked and compromised by increasingly sophisticated cyberattacks.
View ArticleData breaches create insurance costs
Cyber attacks. Data breaches. Cyber crime. They've made headlines, and dealing with them is a growing business expense that can run into the millions of dollars for bigger companies.
View ArticleGene discovery prevents weight gain with a high-sugar diet
Imagine being able to take a pill that lets you eat all of the ice cream, cookies, and cakes that you wanted – without gaining any weight.
View ArticleUS Supreme Court weighs generic drug dispute
(AP)—The US Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world's best-selling multiple sclerosis treatment.
View ArticleWater purification at the molecular level
(Phys.org) —Fracking for oil and gas is a dirty business. The process uses millions of gallons of water laced with chemicals and sand. Most of the contaminated water is trucked to treatment plants to...
View ArticleStartup measures movement in cells to improve cancer drug development
Officials at a life sciences startup based on a Purdue University innovation say their technology could help pharmaceutical companies find more effective drug candidates and improve the results of...
View ArticleRomark Laboratories to open plant in Puerto Rico
(AP)—Puerto Rico's governor says Florida-based pharmaceutical company Romark Laboratories L.C. is building a $110 million plant in the U.S. territory.
View ArticleNew technology could speed up life-saving drug discoveries
A team of researchers from our University has developed a revolutionary new biochip device that will lead to a faster and more cost effective way of discovering new life-saving drugs.
View ArticleA new 'metrics toolkit' to measure and evaluate how green a chemical reaction is
Chemists at the University of York have developed a new 'metrics toolkit' to measure and evaluate how green a reaction is.
View ArticleCounterfeiters push fashion labels to new heights
The presence of counterfeiters in the market can drive innovation in the fashion industry, according to a new study from the University of British Columbia.
View ArticleGlobal pharma firms grilled about tax in Australia
The world's top pharmaceutical companies Wednesday told an Australian parliamentary hearing they were compliant with local and international laws, despite claims they are charging higher prices to...
View ArticleHow an important enzyme used in drug production recognizes its substrate
A research group at the University of Tokyo has demonstrated the mechanism by which an enzyme used in industrial production of an important drug for type-2 diabetes recognizes its target. This finding...
View ArticleIBM acquires medical imaging firm to help Watson 'see' (Update)
IBM said Thursday it was boosting the capacity of its Watson supercomputer, acquiring the medical imaging group Merge Healthcare for $1 billon.
View ArticleStruggles ahead in China for chemical and pharmaceutical companies
China's economic downturn plus other factors, including overcapacity and tightening regulations, mean the next two to three years could be challenging for the foreign chemical and pharmaceutical...
View ArticleTurbocharging drug development and production with less paperwork
Pharmaceutical manufacturing is governed by strict guidelines that necessitate extensive documentation of all steps in the production process. A new Siemens solution for "paperless pharma production"...
View ArticleTapping our microbiomes for new health treatments
Fecal transplants for treating gut diseases were the first reported therapies based on the idea that the human microbiome is inextricably linked to our health. Now, as researchers further flesh out...
View ArticleHow GE's new Boston home went from cold to hot (Update)
Before it became a boomtown, Boston's Seaport District—soon the new home of General Electric's global headquarters—was a dreary backwater.
View ArticleFinding needles in chemical haystacks
A team of chemists including Daniel Weix from the University of Rochester has developed a process for identifying new catalysts that will help synthesize drugs more efficiently and more cheaply. The...
View ArticleStudy provides new focus for developing drugs to fight cancer
Cancer researchers and drug companies may have been too quick to ignore a promising line of inquiry that targets a specific cell protein, according to a research team led by a biomedical scientist in...
View ArticleOpinion: Greedy academic journal publishers behind knowledge inequality
Publishers of academic journals make more profit than pharmaceutical companies. "Fifty percent of all research publications in the world are owned by five publishing houses with an average profit...
View ArticleUS drugmaker Eli Lilly to cut 3,500 jobs
Eli Lilly will cut 3,500 jobs and close some drug manufacturing and research facilities in a cost-cutting drive, the US pharmaceutical company announced Thursday.
View ArticleHow a Native American tribe came to own one of the world's most valuable patents
Allergan, the drugmaker behind Botox, is using an unprecedented tactic to protect its valuable patents – angering lawyers and politicians, and keeping the price of its medicines high.
View Article
